Home/R-Bio/Cameron Owen

CO

Cameron Owen

CEO & Co-founder

Therapeutic Areas

Endocrinology Diabetes

R-Bio Pipeline

Drug	Indication	Phase
R-biolin	Diabetes (Insulin replacement)	Pre-clinical

Leadership Team at R-Bio

Deenadayalan Bakthavatsalam, PhD

Chief Scientific Officer

View full R-Bio profile